Mississauga, Ontario

In the rapidly evolving field of genomics, the need for fast, accurate, and precise variant interpretation has never been greater. As the volume of genetic data expands, traditional methods struggle to keep pace, often delaying critical insights. AI has emerged as the key to overcoming these challenges, offering unparalleled speed and accuracy in interpreting complex genomic variants. At GenomeArc, we’ve developed Horizon Intelligence (HI), an AI-driven engine trained with GenomeArc’s proprietary molecular genomics databases designed to revolutionize variant interpretation, enabling clinicians and researchers to make fast and evidenced based precise decisions.

Symptom Based Gene Panel and Integration of Variants:

As we continue our journey at GenomeArc, integrating AI into our core offerings, the progress is accelerating. Horizon Intelligence, our cutting-edge AI, powers the GenomeArc Horizon Platform, offering ACMG-guided diagnostic insights, pharmacogenomics, and multi-OMICs analysis (including single-cell transcriptomics and proteomics). This seamless integration of HI empowers scientists, healthcare providers, and researchers to incorporate clinical symptoms into the design of highly efficient gene panels, enabling them to search the genome for relevant mutations. By linking unstructured phenotypic data with genomic information, this approach provides clinicians and scientists with valuable diagnostic and therapeutic insights. 

The momentum is incredible, yet we’ve only begun to explore AI’s potential in transforming healthcare and genomics.

Intelligent Prompt for Molecular Genomics and Medicine:

As a Canadian biotech, our approach is both ambitious and responsible. We are committed to pushing the boundaries of AI while embedding safeguards and working with governments and experts to address potential risks as AI becomes even more advanced. With Horizon Intelligence, we are continually investing in the best tools, infrastructure, and foundational models to ensure our technology benefits not just GenomeArc, but the entire ecosystem of genomics and healthcare.



“Today, I’m proud to introduce Horizon Intelligence—the heart of the GenomeArc Horizon Platform. This sophisticated AI engine delivers state-of-the-art performance across genomics applications, helping us realize the vision we had when we founded GenomeArc. The integration of Horizon Intelligence marks one of our biggest achievements in science and engineering, and I’m genuinely excited for the future. Horizon Intelligence will unlock new opportunities, driving personalized medicine and expanding the frontiers of genomic research.” said Dr. Mohammed Dafil, Founder and CEO, GenomeArc.